Luxeptinib inhibited the release of three cytokines from THP-1 monocytes and macrophages at concentrations of 0.1 µM and above.
[Biochemical Pharmacology]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Human Immunology News Luxeptinib Disables NLRP3 Inflammasome-Mediated IL-1β Release and Pathways Required for Secretion of...
